Literature DB >> 19995385

Anthrax lethal toxin promotes dephosphorylation of TTP and formation of processing bodies.

Edith M C Chow1, Sarah Batty, Jeremy Mogridge.   

Abstract

Anthrax lethal toxin (LeTx) is composed of protective antigen (PA) and lethal factor (LF) - PA is the receptor-binding moiety and LF is a protease that cleaves mitogen-activated protein kinase kinases (MAPKKs). LeTx subverts the immune response to Bacillus anthracis in several ways, such as downregulating interleukin-8 (IL-8) by increasing the rate of IL-8 mRNA degradation. Many transcripts are regulated through cis-acting elements that bind proteins that either impede or promote degradation. Some of these RNA-binding proteins are regulated by MAPKs and previous work has demonstrated that interfering with MAPK signalling decreases the half-life of IL-8 mRNA. Here, we have localized a segment within the IL-8 3' untranslated region responsible for LeTx-induced transcript destabilization and show that this is caused by inhibition of the p38, ERK and JNK pathways. TTP, an RNA-binding protein involved in IL-8 mRNA decay, became hypophosphorylated in LeTx-treated cells and knock-down of TTP prevented LeTx from destabilizing the IL-8 transcript. Cells that were treated with LeTx exhibited increased localization of TTP to Processing bodies, which are structures that accumulate transcripts targeted for degradation. We furthermore observed that LeTx promoted the formation of Processing bodies, revealing a link between the toxin and a major mRNA decay pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995385      PMCID: PMC2859114          DOI: 10.1111/j.1462-5822.2009.01418.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  42 in total

Review 1.  The cap-to-tail guide to mRNA turnover.

Authors:  C J Wilusz; M Wormington; S W Peltz
Journal:  Nat Rev Mol Cell Biol       Date:  2001-04       Impact factor: 94.444

2.  Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.

Authors:  G Vitale; L Bernardi; G Napolitani; M Mock; C Montecucco
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

3.  Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway.

Authors:  E Carballo; H Cao; W S Lai; E A Kennington; D Campbell; P J Blackshear
Journal:  J Biol Chem       Date:  2001-09-06       Impact factor: 5.157

4.  Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation.

Authors:  C Y Chen; R Gherzi; J S Andersen; G Gaietta; K Jürchott; H D Royer; M Mann; M Karin
Journal:  Genes Dev       Date:  2000-05-15       Impact factor: 11.361

5.  A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles.

Authors:  Theophany Eystathioy; Edward K L Chan; Scott A Tenenbaum; Jack D Keene; Kevin Griffith; Marvin J Fritzler
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

6.  Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA.

Authors:  W S Lai; E Carballo; J M Thorn; E A Kennington; P J Blackshear
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

7.  Highly selective actions of HuR in antagonizing AU-rich element-mediated mRNA destabilization.

Authors:  Chyi-Ying A Chen; Nianhua Xu; Ann-Bin Shyu
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

8.  Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin.

Authors:  J L Erwin; L M DaSilva; S Bavari; S F Little; A M Friedlander; T C Chanh
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

9.  Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.

Authors:  Esther Suswam; Yanyan Li; Xiaowen Zhang; G Yancey Gillespie; Xuelin Li; John J Shacka; Liang Lu; Lei Zheng; Peter H King
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

10.  Anthrax lethal toxin impairs IL-8 expression in epithelial cells through inhibition of histone H3 modification.

Authors:  Benoit Raymond; Eric Batsche; Florence Boutillon; Yong-Zheng Wu; Dominique Leduc; Viviane Balloy; Eloïse Raoust; Christian Muchardt; Pierre L Goossens; Lhousseine Touqui
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

View more
  6 in total

1.  Acquired coagulant factor VIII deficiency induced by Bacillus anthracis lethal toxin in mice.

Authors:  Der-Shan Sun; Po-Chien Lee; Jyh-Hwa Kau; Yung-Luen Shih; Hsin-Hsien Huang; Chen-Ru Li; Chin-Cheng Lee; Yu-Ping Wu; Kuo-Ching Chen; Hsin-Hou Chang
Journal:  Virulence       Date:  2015-04-23       Impact factor: 5.882

Review 2.  Bacterial Virulence Factors: Secreted for Survival.

Authors:  Aditya Kumar Sharma; Neha Dhasmana; Neha Dubey; Nishant Kumar; Aakriti Gangwal; Meetu Gupta; Yogendra Singh
Journal:  Indian J Microbiol       Date:  2016-11-05       Impact factor: 2.461

Review 3.  Role of MAPK p38 in the cellular responses to pore-forming toxins.

Authors:  Helena Porta; Angeles Cancino-Rodezno; Mario Soberón; Alejandra Bravo
Journal:  Peptides       Date:  2010-06-25       Impact factor: 3.750

Review 4.  The control of inflammation via the phosphorylation and dephosphorylation of tristetraprolin: a tale of two phosphatases.

Authors:  Andrew R Clark; Jonathan L E Dean
Journal:  Biochem Soc Trans       Date:  2016-10-15       Impact factor: 5.407

Review 5.  Bacillus anthracis edema factor substrate specificity: evidence for new modes of action.

Authors:  Martin Göttle; Stefan Dove; Roland Seifert
Journal:  Toxins (Basel)       Date:  2012-07-06       Impact factor: 4.546

Review 6.  Cellular and physiological effects of anthrax exotoxin and its relevance to disease.

Authors:  David E Lowe; Ian J Glomski
Journal:  Front Cell Infect Microbiol       Date:  2012-06-01       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.